The Alzheimer’s Foundation of America (AFA) is encouraging individuals to be proactive about their brain health and wellness by getting a free, confidential memory screening this November as part of Alzheimer’s Awareness Month and National Memory Screening Month.
The National Institute on Aging, part of the National Institutes of Health, has awarded researchers at NYU Rory Meyers College of Nursing a $6.1 million grant to study a program designed to bring effective care to people with dementia receiving hospice care. The two-phase, five-year grant will fund the first large-scale clinical trial of people with dementia in hospice and their caregivers.
Results from two studies show that a new, non-invasive imaging device can see signs of Alzheimer’s disease in a matter of seconds. The researchers show that the small blood vessels in the retina at the back of the eye are altered in patients with Alzheimer’s.
• Patients with acute kidney injury had more than a 3-fold higher risk of developing dementia compared with those without acute kidney injury during a median follow-up time of 5.8 years. • Results from the study will be presented at ASN Kidney Week 2018 October 23–October 28 at the San Diego Convention Center.
In this issue, find research on infant sugary drink consumption, China's top 20 health challenges, aging and healthy years in the Netherlands, and increasing opioid use in Massachusetts
Audio from the American Neurological Association’s 143rd Annual Meeting media roundtable, held October 22, 2018, is now available. At the roundtable, presenters of the meeting’s six principal symposia presented highlights, discussed the relevance of the work, and answered questions.
The Alzheimer's Drug Discovery Foundation (ADDF) is saddened to hear the news that former Supreme Court Justice Sandra Day O'Connor released a letter today saying she has been diagnosed with the beginning stages of dementia, probably Alzheimer's disease.
As the keynote speaker for the American Neurological Association's Presidential Symposium, “Lewy Body Dementia (LBD): From Symptoms to Synuclein,” Susan Schneider Williams put a human face on the leading-edge science presented at the session.
For the first time, the American Neurological Association’s 143rd Annual Meeting will feature a media roundtable TODAY, October 22, 2018 from 11:50-1:00 p.m. at which presenters of the six principal symposia will present highlights, discuss the relevance of the work, and answer questions.
Embargoed abstracts to be presented at the American Neurological Association’s 143rd Annual Meeting October 21-23, 2018 at the Hyatt Regency Atlanta are now available to journalists upon request.
Methods to more precisely inject stem cells into the spinal cord; an enzyme that enhances the synthesis of dopamine in people with Parkinson’s disease; a drug that protects against chemotherapy-induced neuropathy – these are just a few of the exciting research findings that will be presented at the American Neurological Association’s 143rd Annual Meeting October 21-23, 2018 at the Hyatt Regency Atlanta.
Investigators at the West Virginia University Rockefeller Neuroscience Institute performed the first procedure in the world of a phase II trial using focused ultrasound to treat a patient with early stage Alzheimer’s.
In a report of the phase II ADvance clinical trial, Johns Hopkins researchers report that people diagnosed under age 65—those with early-onset Alzheimer’s disease—didn’t benefit from deep brain stimulation. Their findings appeared in the July issue of the Journal of Alzheimer’s Disease.
A multidisciplinary, international group of experts has recommended changing the way clinicians and patients describe cognitive changes experienced in some patients after anesthesia and surgery. The recommendations are being published simultaneously in six peer-reviewed journals including, Anesthesiology.
Stiffness of the aorta – more so than blood pressure or subclinical brain disease – is a key risk factor for dementia. Since aortic stiffness can be reduced by medication and healthy lifestyle changes, these results suggest that people can still lower their dementia risk well into old age.
For the first time, the American Neurological Association’s 143rd Annual Meeting will feature a media roundtable on Monday, October 22, 2018 from 11:50-1:00 p.m. at which presenters of the six principal symposia will present highlights, discuss the relevance of the work, and answer questions. To RSVP for the media roundtable and request dial-in information if you are not able to attend in person, please contact Rachel Brown at [email protected].
Researchers from three Milwaukee-area universities have developed a “stripped-down” estrogen molecule that improves memory in an animal model of post-menopausal dementia, kickstarting new drug discovery for treating memory loss in women.
People with a particular kind of irregular heartbeat called atrial fibrillation may experience a faster decline in thinking and memory skills and have a greater risk of dementia than those without atrial fibrillation, according to a study published in the October 10, 2018, online issue of Neurology®, the medical journal of the American Academy of Neurology.
Researchers present comprehensive genome-wide map of RNA splicing variation in aging brain – novel insights could offer new strategies for diagnosis and treatment of Alzheimer’s disease
Researchers at University of California San Diego School of Medicine, with collaborators across the country, report that people who participate in dementia prevention trials are primarily motivated by altruism and pleased to help.
What you need to know before doing genetic testing
A team of physicists has devised a novel strategy that uses naturally occurring motions inside the human cell nucleus to measure the physical properties of the nucleus and its components. The method offers a potential new means for illuminating the physical properties of unhealthy cells, such as those linked to Alzheimer’s and Parkinson’s disease.
Two UVA Darden School of Business alumni with similar career trajectories, including formative years spent in Silicon Valley before returning to India, are playing key roles in the country’s growth and maturation, offering a front-row perspective on the changes sweeping the country.
The National Institute of Dental and Craniofacial Research and National Institute on Aging have awarded the NYU Rory Meyers College of Nursing with funding to improve the oral hygiene of people with mild dementia. The $3.47 million, five-year grant will be used to implement and study a unique oral health intervention involving family caregivers in New York and North Carolina.
Connecting patients, caregivers and family members with resources and research is the goal behind an annual public conference hosted by the Arizona Alzheimer’s Consortium.
Long-term exposure to periodontal disease bacteria causes inflammation and degeneration of brain neurons in mice that is similar to the effects of Alzheimer’s disease in humans. Periodontal disease may be an initiator of Alzheimer’s.
Two UT Southwestern faculty members have been awarded prestigious National Institutes of Health (NIH) Director’s New Innovator Awards for high-risk, high-reward research.
A new poll shows that only a small percentage of people in their 50s and early 60s have had their DNA tested – either for medical reasons, to learn their ancestry or out of curiosity – but far more have an interest in getting tested. However, two thirds said genetic testing could lead them to worry too much about their future health.
The National Institute on Aging has awarded scientists at University of California San Diego School of Medicine and San Diego State University with a five-year, $4 million grant to boost the number of Latino and other underrepresented minority researchers studying Alzheimer’s disease and related dementias afflicting seniors of Latino origins, a demographic historically overlooked.
Georgetown University Medical Center announces a clinical trial for neurodegenerative disorder Huntington’s disease with the repurposed cancer drug nilotinib.
Researchers at Johns Hopkins report that a novel analysis of more than a thousand patients adds to evidence that hospitalization, critical illness and major infection may diminish brain structures that are most commonly affected by Alzheimer’s disease.
AFA applauds Congress and the Administration for recognizing the importance of putting Alzheimer’s front and center and doing so at an unprecedented level. AFA expresses much gratitude on behalf of all of our nation’s families to members of the Senate and House Appropriations Committee who worked so hard to accomplish this significant development
Rutgers researchers discover possible cause for Alzheimer’s and Traumatic Brain Injury. The new mechanism may have also led to the discovery of an effective treatment.
Las células zombi son aquellas que no pueden morir, pero que tampoco son capaces de realizar las funciones de una célula normal. Estas células zombi, o células senescentes, participan en varias enfermedades relacionadas.
Kim Innes, an epidemiology professor from the West Virginia University School of Public Health, and her team are studying the potential benefits of a simple meditation or music listening practice for improving memory and cognitive functioning, as well as mood, sleep and quality of life in adults with subjective cognitive decline, or SCD.
Scientists at Sanford Burnham Prebys Medical Discovery Institute (SBP) have developed new single-cell approaches wedded to machine learning. This has revealed thousands of previously unknown DNA changes arising during prenatal life in the developing mouse brain. The study published today in PNAS.
During aging, loss of vision and cognition often coincide. In a new study, researchers funded by the National Eye Institute (NEI) and National Institute on Aging (NIA) have found that vision loss precedes loss of mental capacity. The findings suggest that maintaining eye health could help protect cognition in older adults.
僵尸细胞是那些不能死亡但同样无法执行正常细胞功能的细胞。 这些僵尸或衰老细胞涉及许多与年龄有关的疾病。Mayo Clinic的研究人员在《自然》杂志上发表的研究信件中扩大了僵尸细胞的名单。
Nearly 200 academic and industry researchers gathered this week to share updates on preclinical and clinical-stage Alzheimer's disease research at the 19th International Conference on Alzheimer's Drug Discovery. The two-day conference, organized by the Alzheimer's Drug Discovery Foundation (ADDF), focused on gene therapy and alternative modalities for neurodegenerative diseases, progress in developing novel drugs to treat Alzheimer's disease (AD) and related dementias, as well as the need for new biomarkers.
روتشستر، مينيسوتا - خلايا الزومبي هي تلك الخلايا التي لا تموت ولكن لا يمكنها أداء وظائف الخلية الطبيعية بنفس الكفاءة. وتساهم تلك الخلايا الزومبية - أو الخلايا الشائخة - في عدد من الأمراض المرتبطة بعمر الإنسان. وفي رسالة جديدة نُشرت في مجلة الطبيعة "Nature"، استعرض باحثو Mayo Clinic تلك القائمة باستفاضة.
As células zumbis são células que não morrem, mas que também não realizam funções celulares normais. Essas células senescentes, ou zumbis, estão relacionadas a algumas doenças decorrentes da idade. Em um novo artigo publicado na Nature, os pesquisadores da Mayo Clinic ampliaram essa lista.
People who participate in light to moderate physical activity, such as walking at least four hours a week or swimming two to three hours a week, may have less severe strokes than people who are physically inactive, according to a study published in the September 19, 2018, online issue of Neurology®, the medical journal of the American Academy of Neurology.
ROCHESTER, Minn. — Zombie cells are the ones that can't die but are equally unable to perform the functions of a normal cell. These zombie, or senescent, cells are implicated in a number of age-related diseases. And with a new letter in Nature, Mayo Clinic researchers have expanded that list.
Image classification models trained on brain MRIs of dementia patients could help support early diagnosis for more effective treatment.
Astrocytes' important role in brain function suggests they are also involved in disease. Now, scientists at Sanford Burnham Prebys Medical Discovery Institute (SBP) have identified an astrocyte subpopulation as the dominant cell type to spring into action in vivo (in a living organism) in a neuroinflammatory disease setting. The study published today in eNeuro.
A behavioral treatment that helps adults set goals toward a more active social, cognitive, and physical lifestyle can reduce memory decline, in a randomized controlled trial.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right